Microfluidics Market Booming Industry Growth, Research Scope, Advance Technology and Innovations by 2030

The global Microfluidics market testing was valued at ~US$ 21.5 billion in 2021. The market is expected to witness a CAGR of 19.5% from 2022 to 2030.

The growing prevalence of infectious and chronic diseases drives the Microfluidic Devices Market. Microfluidic devices are used for disease screening. Furthermore, microfluidic devices are used in the early detection of cancer. According to the American Cancer Society (ACS), there will be an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States in 2021. Furthermore, the growing geriatric population drives market growth. According to Eurostat, the European Union's statistical office, more than 20.8% of the EU population will be 65 or older in 2021. Because of their slower metabolism and weaker immune systems, the elderly is more vulnerable to infectious and chronic diseases.

The current market is experiencing significant technological advancements. Microfluidics advancements are also enabling the development of a low-cost mass-production process for diagnostic devices, and smartphones combined with microfluidics are enabling the deployment of point-of-care testing. This has broadened the application of microfluidic devices, which is expected to grow further in the future.

Get Sample PDF of the Report: - https://growthplusreports.com/inquiry/request-sample/microfluidics-market/7937

Key Players

• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• Qiagen N.V.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Micronit Microtechnologies
• Cellix
• Microfluidic Chipshop
• Biomérieux
• Fluidigm Corporation
• Danaher Corporation
• Perkinelmer
• Agilent Technologies, Inc.
• Abbott Laboratories
• Nanostring and Nortis Inc.

Microfluidics Market by Product Type

• Microfluidic-based devices
• Microfluidic Components

By Application

• Drug Delivery
• Point-of-Care Diagnostics
• Pharmaceutical and Biotechnology Research
• Clinical Diagnostics

Key Reasons to Purchase:

(1) To gain insightful analyses of the market and have a comprehensive understanding of the global market and its commercial landscape.

(2) Assess the production processes, major issues, and solutions to mitigate the development risk.

(3) To understand the most affecting driving and restraining forces in the Microfluidics Market and its impact in the global market.

(4) Learn about the market strategies that are being adopted by leading respective organizations.

(5) To understand the outlook and prospects for the market.

Key Questions Answered in the Report Include:

(1) This report gives all the information about the industry analysis, revenue, and overview, of this market.

(2) What will be the rate of increase in market size and growth rate by the end of the forecast period?

(3) What is the major global Microfluidics Market trends influencing the development of the market?

(4) What are the vital results of SWOT analysis of the major players operating in the Microfluidics Market?

(5) What are the potential growth opportunities and threats faced by Major competitors in the market?

TOC of Microfluidics Market

1 Scope of the Report

1.1 Market Ecosystem
1.2 Geographic Scope
1.3 Timeline Under Consideration
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Microfluidics Market Executive Summary

2.1 World Market Overview
2.1.1 Global Market Size 2022-2030
2.1.2 Market Size CAGR by Region 2020 VS 2028
2.2 Microfluidics Market Segment by Type
2.2.1 Type 1
2.2.2 Type 2

Browse the full Report now: - https://growthplusreports.com/report/microfluidics-market/7937

Manan Sethi
Director, Market Insights
Email: enquire@growthplusreports.com
Phone no: +91 96545 76783
Web: https://growthplusreports.com/

Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

This release was published on openPR.